Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
A side-by-side table is the most direct way to show a pricing difference, and this one keeps the comparison honest-looking by showing month-by-month rows and a total for each side. Calling the competitor the other guys keeps it general, so anyone paying for GLP-1 elsewhere can map their own plan onto the left column. Eden's column is visually lighter, with its logo in a white header, so the eye lands on it. Eden ran several versions of this creative from September 7, 2026.
At feed size the numbers are tiny, and the totals, which are the whole argument, are no bigger than the monthly rows. A shopper scrolling past sees two dark boxes and a vial, not a saving. Make the two totals the largest numbers on the card (or print the difference as its own line) and cut the rows to what's needed. The ad also gives no reason to switch now; the page's lifetime price guarantee would turn a cheaper total into one that stays cheaper.
It speaks to people who already find GLP-1 pricing confusing, which is a problem they recognize.
It lets the viewer compare plans the way they'd compare quotes, row by row.
It restates the flat price and adds the care promise the table doesn't cover.
$99 every month, framed against an unnamed competitor plan whose monthly price changes, with pay as you go and cancel anytime.
The ad lands on Eden's GLP-1 affiliate page, a focused landing page. The hero repeats the flat-price idea with monthly pricing at every dose for both medications, and the treatment comparison section further down gives the visitor more comparison to read. The page doesn't repeat this ad's provider-versus-provider table near the top, so the specific argument that got the click (their total versus ours) has to be remembered rather than re-seen. Putting a version of the table right under the hero would close that gap.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.